The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Faster and sustained improvement in health-related quality of life (HRQoL) for newly diagnosed multiple myeloma (NDMM) patients ineligible for transplant treated with daratumumab, lenalidomide, and dexamethasone (D-Rd) versus Rd alone: MAIA.
 
Aurore Perrot
Honoraria - Amgen; Celgene; Janssen; Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Sanofi; Takeda
 
Thierry Facon
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda
Speakers' Bureau - celgene; Janssen; Takeda
 
Torben Plesner
Consulting or Advisory Role - Abbvie; Celgene; Genmab; Janssen; Takeda
Research Funding - Janssen
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Seagen; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; Janssen Oncology; Pharmacyclics; Sanofi; Seagen
 
Shaji Kumar
Honoraria - Dr. Reddy's
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Adaptive Biotechnologies; Amgen (Inst); Celgene (Inst); Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
 
Nizar J. Bahlis
Honoraria - Abbvie; Amgen; Celgene; Janssen
Consulting or Advisory Role - Abbvie; Celgene; Janssen
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene; Janssen
 
Karthik Ramasamy
Honoraria - Amgen; Celgene; Janssen; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Janssen; Oncopeptides; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen; Takeda
Research Funding - Amgen; Celgene; Janssen; Takeda
Travel, Accommodations, Expenses - Janssen; Takeda
 
Murielle Roussel
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
Research Funding - Celgene; Janssen
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Takeda
 
Carla Araujo
No Relationships to Disclose
 
Arnaud Jaccard
Honoraria - Celgene; Janssen
Consulting or Advisory Role - Janssen
Research Funding - Celgene; Janssen
Travel, Accommodations, Expenses - Celgene; Janssen
 
Michel Delforge
Honoraria - Amgen; Celgene; Janssen
Consulting or Advisory Role - Amgen; Celgene; Janssen
Research Funding - Celgene; Janssen
 
Caroline McKay
Employment - Janssen; Merck
Stock and Other Ownership Interests - Merck
 
Katharine Gries
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Jeremiah Trudeau
Employment - Janssen
 
Cyrille Hulin
Honoraria - Abbvie; Amgen; Celgene; Janssen-Cilag; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen-Cilag
 
Katja Weisel
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Sanofi; Takeda
Research Funding - Amgen; Celgene; Sanofi